Efficacy of Polymyxin B Hemoperfusion on Severe Sepsis Secondary to Pneumonia or Urinary Tract Infection
Efficacy of Polymyxin B Hemoperfusion on Severe Sepsis Secondary to Pneumonia or Urinary Tract Infection: A Single-arm Clinical Trial
Sponsor: National Taiwan University Hospital
Terminated
Difficult recruitment
Other terminated trials from National Taiwan University Hospital
- Osteoarthritis (OA) of the Knee · Phase NA · Oct 2025
- Early Syphilis · Phase PHASE4 · Jul 2025
- COVID-19 · Phase NA · Feb 2025
- Lung Cancer Patients · Jan 2025
- Ultrasound for Confirmation of Gastric Tube Placement in Critically Ill Patients Under Invasive Mechanical Ventilation · Phase NA · Oct 2023
See all terminations from National Taiwan University Hospital
This NA trial investigates Sepsis and is currently terminated or withdrawn. National Taiwan University Hospital leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Apr 2019 — Jan 2021 [monthly]
Terminated NA
Status: Unknown Status → Terminated · Phase: PHASE2 → NA
-
Sep 2018 — Apr 2019 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Taiwan University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .